Skip to main content
Clinical Trials/JPRN-UMIN000033300
JPRN-UMIN000033300
Completed
未知

Impact of gene polymorphism on the pharmacokinetics and the clinical response in patients with hepatocellular carcinoma using lenvatinib - Gene polymorphism and the pharmacokinetics and clinical response of lenvanib

Juntendo University Nerima Hospital0 sites60 target enrollmentJuly 5, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Juntendo University Nerima Hospital
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 5, 2018
End Date
July 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients regarded as inappropriate subject 2\. Patients who lack of ability of judgement, despite fulfill the listed above

Outcomes

Primary Outcomes

Not specified

Similar Trials